EIFFEL TECHNOLOGIES LIMITED (EIF.AX)
From ValueWiki
Business Description from asx.com.au: Chemically re-engineer drugs to improve performance (potentially reducing dosage and side effects) and allowing use of more efficient, patient-friendly, drug delivery options ie. oral, inhalational, injectable, transdermal and implants.[1]
|
|
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
News Feed
Leadership
- EIFFEL TECHNOLOGIES LIMITED Executive Information
- EIFFEL TECHNOLOGIES LIMITED Directors / Senior Management[1]
Mr Thomas Hartigan (Chairman, Non Exec. Director) Mr Ian Atkin (CFO) Mr Bruce Hundertmark (Director) Mr Michael Hoy (Director) Mr Roderick Tomlinson (Non Exec. Director) Dr Ross Macdonald (Non Exec. Director) Dr Pascal Hickey (Chief Op. Officer)
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
Research Links
- EIFFEL TECHNOLOGIES LIMITED Profile
- EIFFEL TECHNOLOGIES LIMITED Fundamentals
- EIFFEL TECHNOLOGIES LIMITED Technical Analysis
- EIFFEL TECHNOLOGIES LIMITED Contact Information[1]
- Website: http://www.eiffeltechnologies.com.au
- Address: 3 Innovation Road , SYDNEY , NSW, AUSTRALIA, 2113
- Phone: (02) 9805 0022
- Fax: (02) 9805 0044
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 3 , 60 CARRINGTON STREET , SYDNEY , NSW, AUSTRALIA, 2000
- Share Registry Phone: 1300 787 272 (BKR ONLY)
- EIFFEL TECHNOLOGIES LIMITED Message Boards
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=EIF ASX.com.au
- ↑ This is a sample reference.
